Lundi, 13 Juillet 2020
Dernières nouvelles
Principale » Mistake in birth control packaging could result in unintended pregnancy

Mistake in birth control packaging could result in unintended pregnancy

09 Juin 2017

A Baltimore-based company is recalling some of its birth control pills, due to the risk of contraceptive failure, according to the FDA. A market complaint, which has reportedly been confirmed, indicate that a packaging error has rotated the blister 180 degrees within the wallet, which reverses the weekly tablet orientation, and meant those on the first four days of therapy would have had the four non-hormonal placebo tablets, instead of the active tablets.

Lupin Pharmaceuticals has voluntarily recalled one lot of its oral contraceptive Mibelas 24 F-E tablets after a consumer noticed a packaging error.

The pills were distributed across the U.S.to wholesalers, clinics and retail pharmacies."The reversing order may not be apparent to either new users or previous users of the product, increasing the likelihood of taking the tablets out of order", said the FDA.

The recall is for Lot No. L600518.

Federal Bureau of Investigation ex-head Comey accuses Trump administration of defaming him, telling 'lies'
Comey says he did offer the president that "assurance", but resisted Trump's appeals to make that information public. Comey has submitted for todays hearing is disturbing", Mr.

Lupin is notifying distributors and customers with a recall letter, and is collecting all of the recalled medication.

Any one who has purchased the product should notify their physician and return the product to the pharmacy or place of purchase. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking this drug product.

Consumers with questions regarding this recall can contact Lupin by phone 1-800-399-2561, 8:00 am to 5:00 pm EST, Monday through Friday.

Mistake in birth control packaging could result in unintended pregnancy